Drug intelligence / Profile preview

Algopedol

Development stage
Unknown
Lead developer
Laboratoires Crinex
Modality
Small Molecules
Administration
Oral
01

Overview

Algopedol is a 24% sucrose (saccharose) oral solution developed and distributed by Laboratoires Crinex. It is specifically designed for use in newborns and infants up to four months of age to provide comfort and manage pain during minor medical procedures, such as blood sampling, vaccinations, and dressing removals. Classified as a Class I medical device in France, the solution is preservative-free and packaged in 2 ml single-dose units. Its mechanism of action relies on the analgesic effect of oral sucrose, which is believed to stimulate the release of endogenous opioids; this effect is significantly enhanced when the administration is combined with non-nutritive sucking.

Brand names
Algopedol
Other names
sucrose solutionsaccharose solution
02

Targets

TAS1R2 (Taste receptor type 1 member 2)

Beyond the preview

Go deeper on Algopedol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Algopedol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call